Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...
News-Medical.Net on MSN
Highly sensitive CRISPR-based method designed to detect low-frequency cancer mutations
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...
In a new paper presented at IEDM 2025, imec reports on the successful fabrication of highly uniform nanopores with diameters ...
Expanded newborn genetic screening can diagnose hundreds of actionable conditions, allowing for earlier treatment.
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
Poster presentation highlights promising results from Phase 1b/2 TENACITY-01 study of CTD402 in T-Cell and myeloid leukemiasFindings underscore ...
Owkin shares promising validation results for BRCAura RUO, a clinical-grade research-use-only AI product designed to screen for germline BRCA1/2 mutations (gBRCAm) directly from digitized breast ...
Enhancing Ireland’s Competitiveness: The Action Plan’s focus on streamlining planning, regulatory, and legal processes will ...
Terns Pharmaceuticals, Inc. ( TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 PM EST ...
Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025
People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback